Related Experiment Videos
Biliary atresia: 50 years after the first kasai
1Division of Pediatric Surgery, Department of Pediatrics, University Hospital of Geneva, 1211 Geneva, Switzerland.
ISRN Surgery
|January 11, 2013
Summary
Biliary atresia, a rare neonatal liver disease, causes severe cholestasis. Early surgical intervention via hepatoportoenterostomy improves outcomes and may delay liver transplantation.
Area of Science:
- Neonatology
- Pediatric Surgery
- Hepatology
Background:
- Biliary atresia is a rare neonatal disease causing severe cholestasis and biliary cirrhosis.
- It is the most frequent surgical cause of cholestatic jaundice in neonates.
- Untreated, it leads to death in early childhood.
Purpose of the Study:
- To discuss modifications of the Kasai hepatoportoenterostomy for biliary atresia.
- To emphasize the importance of early diagnosis and surgical intervention.
- To highlight the role of liver transplantation in advanced cases.
Main Methods:
- Review of surgical techniques for hepatoportoenterostomy (Kasai procedure).
- Discussion of treatment sequence involving Kasai procedure and potential liver transplantation.
- Emphasis on clinical signs: cholestatic jaundice, pale stools, hepatomegaly.
Main Results:
- Early hepatoportoenterostomy can restore biliary flow and reduce liver damage.
- Timely Kasai procedure can delay or obviate the need for liver transplantation.
- Biliary atresia is the most common pediatric indication for liver transplantation.
Conclusions:
- Early surgical intervention for biliary atresia is crucial for improving patient outcomes.
- Systematic screening for biliary atresia is warranted due to its severity.
- The Kasai procedure, when performed early, significantly impacts long-term prognosis.